Show simple item record

dc.contributor.authorGichangi, P
dc.contributor.authorVuyst, H. De
dc.contributor.authorEstambale, B
dc.contributor.authorRogo, K
dc.contributor.authorBwayo, J
dc.contributor.authorTemmerman, M
dc.date.accessioned2024-02-16T12:05:30Z
dc.date.available2024-02-16T12:05:30Z
dc.date.issued2001
dc.identifier.citationGichangi, P., De Vuyst, H., Estambale, B., Rogo, K., Bwayo, J., & Temmerman, M. (2002). HIV and cervical cancer in Kenya. International Journal of Gynecology & Obstetrics, 76(1), 55-63.en_US
dc.identifier.urihttp://ir.tum.ac.ke/handle/123456789/17396
dc.descriptionhttps://doi.org/10.1016/S0020-7292(01)00560-4en_US
dc.description.abstractObjecti es: To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital KNH from Ž . 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9-year period when national HIV prevalence went from 5% to 5 10%, to 10 15%. Results: There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 5% women who were tested for HIV, Ž . 36 31% were seropositive. These women were 5 years younger at presentation than HIV-negative women. Ž . Conclusions: A two- to three-fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV-positive women who presented with cervical cancer were significantly younger than HIV-negative women. 2002 International Federation of Gynecology and Obstetrics. All rights reserved.en_US
dc.description.sponsorshipTECHNICAL UNIVERSITY OF MOMBASAen_US
dc.language.isoenen_US
dc.subjectHIVen_US
dc.subjectCervical canceren_US
dc.subjectKenyaen_US
dc.titleHIV and cervical cancer in Kenyaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record